Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade

Sequential combination of immunogenic cell death (ICD)-induced interventions with subsequent immunotherapy has shown efficacy in preclinical models and clinical evaluation. Recently, a clinical trial enrolling small cell lung cancer patients treated with amrubicin together with PD-1 blockade confirm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroemer, Guido, Kepp, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565809/
https://www.ncbi.nlm.nih.gov/pubmed/34745770
http://dx.doi.org/10.1080/2162402X.2021.1996686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565809/
https://www.ncbi.nlm.nih.gov/pubmed/34745770
http://dx.doi.org/10.1080/2162402X.2021.1996686

Ejemplares similares